百奧賽圖－Ｂ：2024年度報告.pdf

1、ANNUAL REPORT年 度 報 告Stock code 股份代號：2315百奧賽圖北京醫藥科技股份有限公司Biocytogen Pharmaceuticals(Beijing)Co.,Ltd.(A joint stock company incorporated in the Peoples Republic of China with limited liability)（於中華人民共和國註冊成立的股份有限公司）20241 1百奧賽圖(北京)醫藥科技股份有限公司 二零二四年年報目錄 Contents公司資料2Corporate Information釋義6Definition主席報告1

2、9Chairmans Statement管理層討論與分析22Management Discussion and Analysis董事、監事及高級管理層68Directors,Supervisors and Senior Management企業管治報告81Corporate Governance Report董事會報告108 Directors Report環境、社會及管治報告157 Environmental,Social and Governance Report附錄一：內部政策一覽表197 Appendix I:Summary of Internal Policies附錄二：環境關鍵績效

3、指標摘要199 Appendix II:Environmental Key Performance Indicators Summary Table附錄三：聯交所 環境、社會及管治報告指引 索引201 Appendix III:Index of HKEXs Environmental,Social and Governance Reporting Guide獨立核數師報告207 Independent Auditors Report綜合損益及其他全面收入表214 Consolidated Statements of Profit or Loss and Other Comprehensive

4、Income綜合財務狀況表215 Consolidated Statements of Financial Position綜合權益變動表217 Consolidated Statements of Changes in Equity綜合現金流量表218 Consolidated Cash Flow Statements綜合財務報表附註221 Notes to the Consolidated Financial Statements財務概要336 Financial Summary2Biocytogen Pharmaceuticals(Beijing)Co.,Ltd.Annual Repor

5、t 2024公司資料Corporate InformationCHINESE NAME百奧賽圖(北京)醫藥科技股份有限公司ENGLISH NAMEBiocytogen Pharmaceuticals(Beijing)Co.,Ltd.*LEGAL REPRESENTATIVEDr.Shen YueleiCHAIRMAN OF THE BOARDDr.Shen YueleiHEAD OFFICES AND PRINCIPLE PLACE OF BUSINESS IN CHINA12 Baoshen South StreetDaxing Bio-Medicine Industry ParkDaxin

6、g District,BeijingPRCREGISTERED OFFICE12 Baoshen South StreetDaxing Bio-Medicine Industry ParkDaxing District,BeijingPRCPRINCIPAL PLACE OF BUSINESS IN HONG KONG40th Floor,Dah Sing Financial CenterNo.248 Queens Road EastWanchaiHong Kong中文名稱百奧賽圖（北京）醫藥科技股份有限公司英文名稱Biocytogen Pharmaceuticals (Beijing)Co.